Market Research Report
Onychomycosis - Market Insights, Epidemiology and Market Forecast 2028
|Published by||DelveInsight Business Research LLP||Product code||773931|
|Published||Content info||100 Pages
Delivery time: 1-2 business days
|Onychomycosis - Market Insights, Epidemiology and Market Forecast 2028|
|Published: January 1, 2019||Content info: 100 Pages||
DelveInsight's "Onychomycosis - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Onychomycosis epidemiology and market outlook for the
Onychomycosis (Tinea Unguium or nail fungus) can be described as a fungal infection that causes fingernails or toenails to thicken, discolor, disfigure, and split. It is a common condition that begins as a white or yellow spot under the tip of the fingernail or toenail. As the fungal infection goes deeper, nail fungus may cause the patient's nails to crumble at the edge. In case the condition is mild and not painful, it may not be required to consult a doctor. However, if the nail fungus is painful and has caused severe thickening of the nails, self-care steps and medications may help. If the problem is caused by a bacterium, the condition is called paronychia.
Onychomycosis occurs from the overgrowth of fungi in, under, or on the nail. Fungi thrive in warm, moist environment, so this type of environment can cause the fungi to naturally overpopulate. The same fungi that is responsible for causing jock itch, athlete's foot, and ringworm can cause nail infections. The people who are suffering from diabetes, have a disease that causes poor circulation, are over age 65, wear artificial nails, swim in a public swimming pool, have a nail or skin injury, or wear closed-toe shoes are at higher risk of developing the disease.
Study Period: 2016-2028
The market report provides the overview of the Onychomycosis by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches and therapy areas under research and development for 7MM.
The report provides a comprehensive account of the total patient pool, diagnosed cases and potential patient pool eligible for the treatment. It also includes the explanation of changing trends of epidemiology after evaluating numerous studies, survey reports and views of key opinion leaders. The Report provides the 10 years forecast from 2016 to 2028 segmented by seven major markets, enabling to understand the potential of the Onychomycosis in the respective markets. The epidemiology data is presented with graphs and tables to provide a clear assessment of the landscape.
The drug chapter segment covers the complete analysis of marketed drugs and Phase III & late Phase II pipeline drugs. This division focuses on the recent breakthroughs like clinical development analysis, agreements and collaborations, clinical trial details, allotted designations, published results, pharmacological effects, patent expiry, and expected launch timings. Moreover, advantages and disadvantages of the therapy along with opinion of experts for marketed and emerging drugs are also provided.
The report's market outlook delivers an understanding of the country-specific revenue and share by analyzing the performance of the current therapies and potential uptake of new products. The in-depth analysis helps to recognize the growing demand of the market by evaluating the annual cost of therapy, compliance rate, competition with other therapies, covered patient segment, impact of emerging technology in the forecast period. The views from the key opinion leaders adds more value to the analysis. This segment provides the relevant graphs and tables to have an effective outline of the Onychomycosis market.
This division provides an understanding of the rate of drug uptake, drugs including both recently launched and those which show potential to get launched during the forecast period from 2016-2028. The analysis is based on patient uptake by therapies, sales projection of each drug by studying the reasons behind the maximal use of new drugs. A comparative analysis is also done on the basis of market share and size by assessing the drugs uptake to project the drug positioning in the market.